Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric comparison of fixed-dose dispersible antiretroviral tablets versus liquid formulations
RBR-9nq7qdPhase 2Recruiting
- Sponsor
- Universidade Federal de Minas Gerais
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of nevirapine, lamivudine and zidovudine in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Universidade Federal de Minas Gerais. Primary endpoints: Pharmacokinetic comparison and Formulation comparison. Started Oct 2015; status: recruiting.
02
Drugs
nevirapinelamivudinezidovudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on RBR-9nq7qd.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9nq7qd.